At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Mitopure Topical Formula (other)
- How long the study runs
- Study runs about 1 month (dates as stated)
- About the drug or intervention
- Mitopure Topical Formula — other: Topical skin serum containing Mitopure
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 40
- Started
- 2026-04-20
- Last checked
- 2026-06
Plain English Summary
What is this study?
- • Testing a new treatment for healthy adult
- • NA - 40 participants
- • The objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with healthy adult
Where?
- • Manchester - PCR Corp
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers.
Healthy Adult
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Healthy male and female participants aged 18+.
- ✓Participant has signed a written agreement to take part.
- ✓Participant must agree to refrain from taking any new medications or herbal supplements during the study, unless...
- ✓Participant does not have grade of 3 or higher of any skin attribute per the grading scale.
- ✓Participant is willing to ONLY use the test article on themselves during the study as instructed and not use other...
Who cannot take part
- ✗Participant is pregnant, nursing, or planning to become pregnant (by verbal response only).
- ✗Participant has a current skin disease of any type (e.g., eczema, psoriasis, rosacea, atopic dermatitis, vitiligo).
- ✗Participant has a known allergy to face serum products, or the ingredients included in the test article.
- ✗Participant has a history of malignant disease.
- ✗Participant has cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on their face that may...
See the full criteria
Inclusion Criteria:
* Healthy male and female participants aged 18+.
* Participant has signed a written Informed Consent.
* Participant must agree to refrain from taking any new medications or herbal supplements during the study, unless permitted by the investigator.
* Participant does not have grade of 3 or higher of any skin attribute per the grading scale.
* Participant is willing to ONLY use the test article on themselves during the study as instructed and not use other facial serum products.
* Participant is willing to attend all study visits and to follow the study instructions and prohibitions.
* Participant must agree to refrain from using any new facial serum products, cleansers, laundry detergents, fragrances while participating in this study.
Exclusion Criteria:
* Participant is pregnant, nursing, or planning to become pregnant (by verbal response only).
* Participant has a current skin disease of any type (e.g., eczema, psoriasis, rosacea, atopic dermatitis, vitiligo).
* Participant has a known allergy to face serum products, or the ingredients included in the test article.
* Participant has a history of malignant disease.
* Participant has cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on their face that may interfere with assessments.
* Participant has a significant past medical history of hepatic, renal, cardiac, pulmonary, digestive, haematological, neurological, locomotor or psychiatric disease.
* Participant has a known sensitivity to the test article, similar materials, or their constituents.
* Treatment or medication containing sympathomimetics, antihistamines or corticosteroids in the seven days prior to study start.
* Medical condition that may affect study data or participant safety which in the opinion of the Investigator would compromise the safety of the participant or study results.
* History of poor cooperation, non-compliance, or unreliability.
* Investigator deems the participant an unsuitable candidate for the study.
Where Is This Study? (1 UK site)
PCR Corp
Manchester M13 0AF, United Kingdom
Data sourced from ClinicalTrials.gov · Last verified: 2026-06
